Telmisartan to Prevent Recurrent Stroke and Cardiovascular Events

Cited by (785)

Items 101–200 of 785

1. A META-ANALYSIS REPORTING EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS IN PATIENTSWITHOUT HEART FAILURE
   Gianluigi Savarese, Pierluigi Costanzo, John G.F. Cleland, Enrico Vassallo, Donatella Ruggiero, Giuseppe M.C. Rosano, Pasquale Perrone Filardi · 2013 · Rational Pharmacotherapy in Cardiology
2. Intensive versus Guideline Blood Pressure and Lipid Lowering in Patients with Previous Stroke: Main Results from the Pilot ‘Prevention of Decline in Cognition after Stroke Trial’ (PODCAST) Randomised Controlled Trial
   Philip M. Bath, Polly Scutt, Daniel J. Blackburn, Sandeep Ankolekar, Kailash Krishnan, Clive G. Ballard, Alistair S. Burns, Jonathan Mant, Peter Passmore, Stuart Pocock et al. · 2017 · PLoS ONE
3. Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis
   Emma Copland, Dexter Canoy, Milad Nazarzadeh, Zeinab Bidel, Rema Ramakrishnan, Mark Woodward, John Philip Chalmers, Koon Kang Teo, Carl J. Pepine, Barry R. Davis et al. · 2021 · The Lancet Oncology
4. Management of Blood Pressure for Acute and Recurrent Stroke
   Venkatesh Aiyagari, Philip B. Gorelick · 2009 · Stroke
5. Effects of blood-pressure-lowering treatment in hypertension
   Costas Thomopoulos, Gianfranco Parati, Alberto Zanchetti · 2016 · Journal of Hypertension
6. Effects of a fixed combination of perindopril and indapamide in patients with type 2 diabetes and chronic kidney disease
   Hiddo J.L. Heerspink, Toshiharu Ninomiya, Vlado Perkovic, Mark Woodward, Sophia Zoungas, Alan Cass, Mark Emmanuel Cooper, Diederick E. Grobbee, Giuseppe Mancia, Carl Eric Mogensen et al. · 2010 · European Heart Journal
7. Blood Pressure Management for Ischemic Stroke in the First 24 Hours
   Philip M. Bath, Lili Song, Gisele Sampaio Silva, Eva A. Mistry, Nils Petersen, Georgios K. Tsivgoulis, Mikaël Mazighi, Oh Young Bang, Else Charlotte Sandset · 2022 · Stroke
8. Effects of blood pressure-lowering treatment. 6. Prevention of heart failure and new-onset heart failure – meta-analyses of randomized trials
   Costas Thomopoulos, Gianfranco Parati, Alberto Zanchetti · 2016 · Journal of Hypertension
9. Effects of blood pressure-lowering treatment on cardiovascular outcomes and mortality
   Costas Thomopoulos, Gianfranco Parati, Alberto Zanchetti · 2018 · Journal of Hypertension
10. Ramipril-based versus diuretic-based antihypertensive primary treatment in patients with pre-diabetes (ADaPT) study
    Walter Zidek, Joachim Schrader, Stephan Lüders, Stephan Matthaei, Christoph Hasslacher, Joachim D. Hoyer, Claudia Zemmrich, Peter Bramlage, Claus‐Dieter Sturm, W. Dieter Paar · 2012 · Cardiovascular Diabetology
11. Antihypertensive drugs and glucose metabolism
    Christos V. Rizos · 2014 · World Journal of Cardiology
12. Lipids, blood pressure and kidney update 2014
    Maciej Banach, Wilbert S. Aronow, Maria-Corina Șerban, Amirhossein Sahabkar, Jacek Rysz, Luminita E. Voroneanu, Adrian Constantin Covic · 2015 · Pharmacological Research
13. Effects of blood pressure-lowering treatment on cardiovascular outcomes and mortality
    Costas Thomopoulos, Gianfranco Parati, Alberto Zanchetti · 2018 · Journal of Hypertension
14. PPAR Agonists as Therapeutics for CNS Trauma and Neurological Diseases
    Shweta Mandrekar-Colucci, Andrew D. Sauerbeck, Phillip G. Popovich, Dana M. McTigue · 2013 · ASN NEURO
15. ACE-Inhibitors in Hypertension: A Historical Perspective and Current Insights
    Stacey Cutrell, Ibrahim S. Alhomoud, Anurag Mehta, Azita H. Talasaz, Benjamin W. Van Tassell, Dave L. Dixon · 2023 · Current Hypertension Reports
16. Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers and Diabetes: A Meta-Analysis of Placebo-Controlled Clinical Trials
    Giuliano Tocci, Francesco Paneni, Francesca Palano, Sebastiano Sciarretta, Andrea Ferrucci, Theodore W. Kurtz, Giuseppe Mancia, Massimo Volpe · 2011 · American Journal of Hypertension
17. Blood pressure control in Italy
    Giuliano Tocci, Enrico Agabiti Rosei, Ettore Ambrosioni, Claudio Borghi, Claudio Ferri, Andrea Ferrucci, Giuseppe Mancia, Alberto Morganti, Roberto Pontremoli, Bruno Trimarco et al. · 2012 · Journal of Hypertension
18. 2010 Guidelines of the Taiwan Society of Cardiology for the Management of Hypertension
    Chern‐En Chiang, Tzung‐Dau Wang, Yi-Heng Li, Tsung‐Hsien Lin, Kuo‐Liong Chien, Hung‐I Yeh, Kou‐Gi Shyu, Wei-Chuen Tsai, Ting-Hsing Chao, Juey‐Jen Hwang et al. · 2010 · Journal of the Formosan Medical Association
19. Effect of Telmisartan on Functional Outcome, Recurrence, and Blood Pressure in Patients With Acute Mild Ischemic Stroke
    Philip M. Bath, Renée H. Martin, Yuko Y. Palesch, Daniel Cotton, Salim Yusuf, Ralph L. Sacco, Hans‐Christoph Diener, Danilo Toni, Conrado J. Estol, Robin E. Roberts · 2009 · Stroke
20. Blood pressure lowering treatment for preventing stroke recurrence: a systematic review and meta-analysis
    Shaheen Emmanuel Lakhan, Michael T. Sapko · 2009 · International Archives of Medicine
21. Comparison of Risk Factor Reduction and Tolerability of a Full-Dose Polypill (With Potassium) Versus Low-Dose Polypill (Polycap) in Individuals at High Risk of Cardiovascular Diseases
    Salim Yusuf, Prem S Pais, Alben Sigamani, Denis Xavier, Rizwan Afzal, Peggy Gao, Koon Kang Teo · 2012 · Circulation Cardiovascular Quality and Outcomes
22. Influence of blood pressure reduction on composite cardiovascular endpoints in clinical trials
    Paolo Verdecchia, Giorgio Gentile, Fabio Angeli, Giovanni Mazzotta, Giuseppe Mancia, Gianpaolo Reboldi · 2010 · Journal of Hypertension
23. Telmisartan on top of antihypertensive treatment does not prevent progression of cerebral white matter lesions in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) MRI substudy
    Weber, Ralph, Weimar, Christian, Blatchford, Jon, Hermansson, Karin, Wanke, Isabel, Möller-Hartmann, Claudia, Gizewski, Elke R., Forsting, Michael, Demchuk, Andrew M., Sacco, Ralph L. et al. · 2012 · Stroke
24. Hypoalbuminemia Within Two Postoperative Days Is an Independent Risk Factor for Acute Kidney Injury Following Living Donor Liver Transplantation
    Bo‐Hyun Sang, Ji‐Yeon Bang, Jun‐Gol Song, Gyu‐Sam Hwang · 2015 · Critical Care Medicine
25. Placebo-Controlled Trials of Blood Pressure–Lowering Therapies for Primary Prevention of Dementia
    Jan Albert Staessen, Lutgarde Thijs, Tom Richart, Augustine N. Odili, W. H. Birkenhäger · 2010 · Hypertension
26. Next generation multifunctional angiotensin receptor blockers
    Theodore W. Kurtz, Uwe Klein · 2009 · Hypertension Research
27. Effects of blood pressure lowering treatment in hypertension
    Costas Thomopoulos, Gianfranco Parati, Alberto Zanchetti · 2016 · Journal of Hypertension
28. Impact of Hypertension on Stroke
    Jordan S. Dubow, Matthew E. Fink · 2011 · Current Atherosclerosis Reports
29. Promoting higher blood pressure targets for frail older adults: A consensus guideline from Canada
    Laurie Herzig Mallery, Michael Allen, Isobel Fleming, Kim Kelly, Susan K. Bowles, Jill Duncan, Paige A. Moorhouse · 2014 · Cleveland Clinic Journal of Medicine
30. Ischemic Stroke and Secondary Prevention in Clinical Practice
    Signild Åsberg, Karin Maria Henriksson, Bahman Y. Farahmand, Kjell Asplund, Bo G Norrving, Peter Appelros, Birgitta Stegmayr, Kerstin Hulter Åsberg, Andreas Terént · 2010 · Stroke
31. Prevention and management of stroke in very elderly patients
    Nerses Sanossian, Bruce I Ovbiagele · 2009 · The Lancet Neurology
32. Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient
    Alberto Zanchetti, Lisheng Liu, Giuseppe Mancia, Gianfranco Parati, Guido M. Grassi, Marco Stramba‐Badiale, Vincenzo Silani, Grzegorz Bilo, Giovanni Corrao, Antonella Zambon et al. · 2014 · Journal of Hypertension
33. Types of Stroke Recurrence in Patients with Ischemic Stroke: A Substudy from the PRoFESS Trial
    Danilo Toni, Emanuele Di Angelantonio, Maria Teresa Di Mascio, Richard Vinisko, Philip M. Bath, for the PRoFESS Study Group · 2013 · International Journal of Stroke
34. Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers are beneficial in normotensive atherosclerotic patients: a collaborative meta-analysis of randomized trials
    Finlay Aleck McAlister, for the Renin Angiotension System Modulator Meta-Analysis Investigators · 2011 · European Heart Journal
35. Renin Angiotensin Aldosterone System Inhibitors in Hypertension: Is There Evidence for Benefit Independent of Blood Pressure Reduction?
    Chirag Bavishi, Sripal Bangalore, Franz H. Messerli · 2016 · Progress in Cardiovascular Diseases
36. Blood Pressure Variability and Cardiovascular Outcomes in Patients With Prior Stroke
    Adam de Havenon, Nora F. Fino, Brian Johnson, Ka‐Ho Wong, Jennifer Juhl Majersik, David Tirschwell, Natalia S. Rost · 2019 · Stroke
37. Lifestyle interventions for secondary disease prevention in stroke and transient ischaemic attack: a systematic review
    Olive C. Lennon, Rose Galvin, Kathryn Smith, Catherine Doody, Catherine M. Blake · 2013 · European Journal of Preventive Cardiology
38. Telmisartan: A Different Angiotensin II Receptor Blocker Protecting a Different Population?
    Michel Burnier · 2009 · Journal of International Medical Research
39. Impaired Cerebral Autoregulation Is Associated with Brain Atrophy and Worse Functional Status in Chronic Ischemic Stroke
    Mikio Aoi, Kun Hu, Men‐Tzung Lo, Magdy H. Selim, Mette Sofie Olufsen, Vera Novak · 2012 · PLoS ONE
40. Elevated Blood Pressure in the Acute Phase of Stroke and the Role of Angiotensin Receptor Blockers
    Simona Lattanzi, Mauro Silvestrini, Leandro Provinciali · 2013 · International Journal of Hypertension
41. European stroke organisation (ESO) guideline on cerebral small vessel disease, part 2, lacunar ischaemic stroke
    Joanna Marguerite Wardlaw, Hugues Chabriat, Frank‐Erik de Leeuw, Stéphanie Debette, Martin Dichgans, Fergus Doubal, Hanna Jokinen, Aristeidis H. Katsanos, Raffaele Ornello, Leonardo Pantoni et al. · 2024 · European Stroke Journal
42. Trends in blood pressure control in patients with type 2 diabetes – Data from the Swedish National Diabetes Register (NDR)
    Peter M. Nilsson, Jan Cederholm, Björn Zethelius, Björn Eliasson, Katarina Eeg‐Olofsson, Soffia Guðbjörnsdóttir, For The Swedish NDR · 2011 · Blood Pressure
43. Telmisartan: just an antihypertensive agent? A literature review
    Maurizio Destro, Francesca Cagnoni, Giuseppina Patrizia Dognini, Vincenzo Galimberti, Carlo Taietti, C. Cavalleri, Emilio Giulio Galli · 2011 · Expert Opinion on Pharmacotherapy
44. Aerobic exercise interventions reduce blood pressure in patients after stroke or transient ischaemic attack: a systematic review and meta-analysis
    Cheng Wang, Jessica N.E. Redgrave, Mohsen Shafizadeh, Arshad Majid, Karen Kilner, Ali Ali · 2018 · British Journal of Sports Medicine
45. Facts and fallacies of blood pressure control in recent trials: implications in the management of patients with hypertension
    Alberto Zanchetti, Giuseppe Mancia, Henry Richard Black, Suzanne Oparil, Bernard Waeber, Roland Erich Schmieder, George L. Bakris, Franz H. Messerli, Sverre Erik Kjeldsen, Luis Miguel Ruilope · 2009 · Journal of Hypertension
46. Angiotensin receptor blockers and angiogenesis: clinical and experimental evidence
    Lauren Willis, Azza B. El‐Remessy, Payaningal R. Somanath, David L. DeRemer, Susan C. Fagan · 2010 · Clinical Science
47. Pharmacotherapy for hypertension in adults 60 years or older
    Vijaya Manav Musini, Aaron M Tejani, Ken L. Bassett, Lorri J Puil, James M Wright · 2019 · Cochrane Database of Systematic Reviews
48. Current challenges in the clinical management of hypertension
    Luis Miguel Ruilope · 2011 · Nature Reviews Cardiology
49. Systematic review of the effect of telmisartan on insulin sensitivity in hypertensive patients with insulin resistance or diabetes
    Naeti Suksomboon, Nalinee Poolsup, T. Prasit · 2011 · Journal of Clinical Pharmacy and Therapeutics
50. Effect of Combined Aspirin and Extended-Release Dipyridamole Versus Clopidogrel on Functional Outcome and Recurrence in Acute, Mild Ischemic Stroke
    Philip M. Bath, Daniel Cotton, Renée H. Martin, Yuko Y. Palesch, Salim Yusuf, Ralph L. Sacco, Hans‐Christoph Diener, Conrado J. Estol, Robin E. Roberts · 2010 · Stroke
51. Lowering of Blood Pressure for Recurrent Stroke Prevention
    Andrea D. Boan, Daniel T. Lackland, Bruce I Ovbiagele · 2014 · Stroke
52. Renin–angiotensin system blockade for the risk of cancer and death
    Jian Xing Shen, Yanmei Huang, Min Wang, Xuezhi Hong, Xin-Nan Song, Xia Zou, Yan-Hong Pan, Wei Ling, Minhui Zhu, Xiaoxi Zhang et al. · 2016 · Journal of the Renin-Angiotensin-Aldosterone System
53. Therapeutic potential of the renin angiotensin system in ischaemic stroke
    Mariana Moreira Coutinho Arroja, Emma Reid, Christopher McCabe · 2016 · Experimental & Translational Stroke Medicine
54. Blood Pressure and Vascular Cognitive Impairment
    Deborah A. Levine, Mellanie V. Springer, Amy G. Brodtmann · 2022 · Stroke
55. Lipids, blood pressure and kidney update 2015
    Maciej Banach, Wilbert S. Aronow, Maria-Corina Șerban, Jacek Rysz, Luminita E. Voroneanu, Adrian Constantin Covic · 2015 · Lipids in Health and Disease
56. Telmisartan suppresses cerebral injury in a murine model of transient focal ischemia
    Yukiko Kasahara, Akihiko Taguchi, Hisakazu Uno, Akiko Nakano, Takayuki Nakagomi, Haruka Hirose, David M. Stern, Tomohiro Matsuyama · 2010 · Brain Research
57. The Different Therapeutic Choices with ARBs. Which One to Give? When? Why?
    Csaba András Dézsi · 2016 · American Journal of Cardiovascular Drugs
58. Epidemiology, Pathophysiology, and Treatment of Hypertension in Ischaemic Stroke Patients
    Nurain Mohammad Hisham, Ulvi Bayraktutan · 2012 · Journal of Stroke and Cerebrovascular Diseases
59. Clinical trials for preventing post stroke cognitive impairment
    Sandeep Ankolekar, Chamila M. Geeganage, Peter Anderton, Cheryl Hogg, Philip M. Bath · 2010 · Journal of the Neurological Sciences
60. Effect of antihypertensive agents on risk of atrial fibrillation: a meta-analysis of large-scale randomized trials
    Connor A. Emdin, Thomas Callender, Jun Cao, Kazem Rahimi · 2015 · EP Europace
61. Comparative Effectiveness of Blood Pressure-lowering Drugs in Patients who have Already Suffered From Stroke
    Wei‐Ting Wang, Li‐Kai You, Chern‐En Chiang, Shih‐Hsien Sung, Shao‐Yuan Chuang, Hao‐Min Cheng, Chen‐Huan Chen · 2016 · Medicine
62. Stroke in the elderly
    Anjail Zarinah Sharrief, James C. Grotta · 2019 · Handbook of clinical neurology
63. Heightened Cardiovascular Risk in Hypertension Associated With Renin‐Independent Aldosteronism Versus Renin‐Dependent Aldosteronism: A Collaborative Study
    Jinbo Hu, Hang Shen, Peiqi Huo, Jun Yang, Peter J. Fuller, Kanran Wang, Yi Yang, Linqiang Ma, Qingfeng Cheng, Lilin Gong et al. · 2021 · Journal of the American Heart Association
64. The Pivotal Role of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Hypertension Management and Cardiovascular and Renal Protection: A Critical Appraisal and Comparison of International Guidelines
    Luis Antonio Alcocer, Alfonso Bryce, David Brasil, Joffre J. Lara-Terán, Javier Moreno Cortes, Daniel Quesada, Pablo Rodriguez · 2023 · American Journal of Cardiovascular Drugs
65. Potential of the Angiotensin Receptor Blockers (ARBs) Telmisartan, Irbesartan, and Candesartan for Inhibiting the HMGB1/RAGE Axis in Prevention and Acute Treatment of Stroke
    Kiyoshi Kikuchi, Salunya Tancharoen, Takashi Ito, Yoko Morimoto-Yamashita, Naoki Miura, Koichi Kawahara, Ikuro Maruyama, Yoshinaka Murai, Eiichiro Tanaka · 2013 · International Journal of Molecular Sciences
66. New standards in hypertension and cardiovascular risk management: focus on telmisartan
    Domenico Galzerano · 2010 · Vascular Health and Risk Management
67. Reducing the risk of stroke in type 2 diabetes: pathophysiological and therapeutic perspectives
    Dirk Sander, Mark T. Kearney · 2009 · Journal of Neurology
68. PROGRESS: Prevention of Recurrent Stroke
    Hisatomi Arima, John Philip Chalmers · 2011 · Journal of Clinical Hypertension
69. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers decrease the incidence of atrial fibrillation: a meta-analysis
    Gang Huang, Junbo Xu, Jianxiong Liu, Yong He, Xiao-li Nie, Qiu Li, Yongmei Hu, Si-qin Zhao, Mian Wang, Wenyong Zhang et al. · 2011 · European Journal of Clinical Investigation
70. The impact of ACE inhibition on all-cause and cardiovascular mortality in contemporary hypertension trials: a review
    Roberto Ferrari, Eric H. Boersma · 2013 · Expert Review of Cardiovascular Therapy
71. PPARs: Protectors or Opponents of Myocardial Function?
    Christine Jantina Pol, Melissa Lieu, Konstantinos Drosatos · 2015 · PPAR Research
72. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high vascular risk
    Louis Potier, Ronan Roussel, Yedid Elbez, Michel Marre, Uwe Zeymer, Christopher Michael Reid, Magnus E. Ohman, Kim Allen Eagle, Deepak L. Bhatt, Philippe Gabríel Steg · 2017 · Heart
73. Effects of rosuvastatin combined with olmesartan, irbesartan, or telmisartan on indices of glucose metabolism in greek adults with impaired fasting glucose, hypertension, and mixed hyperlipidemia: A 24-week, randomized, open-label, prospective study
    Christos V. Rizos, Haralampos J. Milionis, Michael S. Kostapanos, Matilda Florentin, Christina E. Kostara, Moses Elisaf, Evangelos N. Liberopoulos · 2010 · Clinical Therapeutics
74. Prognostic Significance of Cystatin C in Patients With ST-Elevation Myocardial Infarction
    Eiji Ichimoto, Kigen Jo, Yoshio Kobayashi, Toshihisa Inoue, Yoshitake Nakamura, Nakabumi Kuroda, Akira Miyazaki, Issei Komuro · 2009 · Circulation Journal
75. The Influence of Propofol and Sevoflurane on Acute Kidney Injury After Colorectal Surgery: A Retrospective Cohort Study
    Ji‐Yeon Bang, Jung-Bok Lee, Jimi Oh, Jun‐Gol Song, Gyu‐Sam Hwang · 2016 · Anesthesia & Analgesia
76. Blood Pressure Management for Stroke Prevention and in Acute Stroke
    Keun‐Sik Hong · 2017 · Journal of Stroke
77. Secondary Ischemic Stroke Prevention
    Aaron Bangad, Mehdi Abbasi, Adam de Havenon · 2023 · Neurotherapeutics
78. Renin-Angiotensin-Aldosterone Blockade for Cardiovascular Disease Prevention
    Krishnaswami Vijayaraghavan, PRAKASH C. DEEDWANIA · 2011 · Cardiology Clinics
79. 2009 Canadian Hypertension Education Program recommendations: The scientific summary – an annual update
    Norm R.C. Campbell, Nadia A. Khan, Michael D. Hill, Guy Tremblay, Marcel Lebel, Janusz A. Kaczorowski, Finlay Aleck McAlister, Richard Z Lewanczuk, Sheldon W. Tobe · 2009 · Canadian Journal of Cardiology
80. Blood pressure management for secondary stroke prevention
    Kazuo Kitagawa · 2022 · Hypertension Research
81. Updates on Prevention of Hemorrhagic and Lacunar Strokes
    Hsin-hsi C Tsai, Jong Sung Kim, Éric Jouvent, M. Edip Gurol · 2018 · Journal of Stroke
82. Discrepancies between Office and Ambulatory Blood Pressure: Clinical Implications
    José R. Banegas, Franz H. Messerli, Bernard Waeber, Fernando Rodríguez‐Artalejo, Álex de la Sierra, J. Segura, Àlex Roca‐Cusachs, Pedro Aranda, Luis Miguel Ruilope · 2009 · The American Journal of Medicine
83. Systolic blood pressure and risk of cardiovascular diseases in type 2 diabetes: an observational study from the Swedish national diabetes register
    Jan Cederholm, Soffia Guðbjörnsdóttir, Björn Eliasson, Björn Zethelius, Katarina Eeg‐Olofsson, Peter M. Nilsson · 2010 · Journal of Hypertension
84. Mega clinical trials which have shaped the RAS intervention clinical practice
    Rainer Düsing · 2016 · Therapeutic Advances in Cardiovascular Disease
85. Influence of admission blood pressure on mortality in patients with acute decompensated heart failure
    Juan Ignacio Pérez‐Calvo, Manuel Montero-Pérez-Barquero, Miguel Camafort, P. Conthe-Gutierrez, Francesç Formiga, Óscar Aramburu‐Bodas, Jorge Manuel Romero-Requena, the RICA Investigators · 2010 · QJM
86. Deleting Death and Dialysis: Conservative Care of Cardio-Vascular Risk and Kidney Function Loss in Chronic Kidney Disease (CKD)
    Raymond Camille Vanholder, Steven Van Laecke, Griet Glorieux, Francis Verbeke, Esmeralda Castillo-Rodríguez, Alberto Ortíz · 2018 · Toxins
87. The Divergent Cardiovascular Effects of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Myocardial Infarction and Death
    Martin H. Strauss, Alistair S. Hall · 2015 · Progress in Cardiovascular Diseases
88. Effect of a Multifaceted Quality Improvement Intervention on the Prescription of Evidence-Based Treatment in Patients at High Cardiovascular Risk in Brazil
    Maria Julia Machline-Carrion, Rafael Marques Soares, Lucas Petri Damiani, Viviane Bezerra Campos, Bruna S. Sampaio, Francisco Antônio Helfenstein Fonseca, Maria Cristina de Oliveira Izar, Celso Amodeo, Octávio Marques Pontes‐Neto, Juliana Yamashita Santos et al. · 2019 · JAMA Cardiology
89. Treatment with angiotensin receptor blockers before stroke could exert a favourable effect in acute cerebral infarction
    Blanca Fuentes, Jéssica Fernández-Domínguez, María de los Ángeles Ortega-Casarrubios, Belén SanJosé, Patricia Martínez‐Sánchez, Exuperio Díez‐Tejedor · 2010 · Journal of Hypertension
90. Review of Long-Term Blood Pressure Control After Intracerebral Hemorrhage: Challenges and Opportunities
    Michael T. Mullen, Craig S. Anderson · 2022 · Stroke
91. Telmisartan as a metabolic sartan: The first meta-analysis of randomized controlled trials in metabolic syndrome
    Hisato Takagi, Masao Niwa, Yusuke Mizuno, Shin-nosuke Goto, Takuya Umemoto · 2013 · Journal of the American Society of Hypertension
92. Incidence, Severity, and Outcomes of AKI Associated with Dual Renin-Angiotensin System Blockade
    Paul M. Palevsky, Jane H. Zhang, Stephen L. Seliger, Nicholas Emanuele, Linda F. Fried, for the VA NEPHRON-D Study · 2016 · Clinical Journal of the American Society of Nephrology
93. Treatment Approaches to Lacunar Stroke
    Alvin S. Das, Robert William Regenhardt, Steven K. Feske, M. Edip Gurol · 2019 · Journal of Stroke and Cerebrovascular Diseases
94. Implications of Recently Published Trials of Blood Pressure–Lowering Drugs in Hypertensive or High-Risk Patients
    Jan Albert Staessen, Tom Richart, Zengwu Wang, Lutgarde Thijs · 2010 · Hypertension
95. RAAS inhibition and mortality in hypertension
    Roberto Ferrari · 2013 · Global Cardiology Science and Practice
96. Hypertension in aging patients
    Alexander G. Logan · 2010 · Expert Review of Cardiovascular Therapy
97. Effects of telmisartan on metabolic syndrome components: a comprehensive review
    Mohsen Imenshahidi, Ali Roohbakhsh, Hossein Hosseinzadeh · 2024 · Biomedicine & Pharmacotherapy
98. The Korean Society of Hypertension Guidelines for the Management of Hypertension in 2013: Its Essentials and Key Points
    Hae‐Young Lee, Jeong Bae Park · 2015 · Pulse
99. Stroke Epidemiology and One-Month Fatality among an Urban Population in Iran
    A. Delbari, Reza Salman-Roghani, Sayed Shahaboddin Tabatabaei, M. Rahgozar, J. Lokk · 2011 · International Journal of Stroke
100. The Year in Hypertension
     Bryan Williams · 2009 · Journal of the American College of Cardiology